Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 289-300 of 1,743
Drug study icon
TerminatedNCT00256997

Risperidone Long-Acting Injection Versus Oral Antipsychotics for schizophrenia

This study was terminated in Australia, in Canada, in the United Kingdom, .... It is testing Risperidone Long-Acting Injection Versus Oral Antipsychotics for schizophrenia.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Australia, Canada, United Kingdom, ...
Sponsor
Janssen-Ortho Inc., Canada
Condition
Schizophrenia
Drug study icon
TerminatedNCT04951609

Seltorexant for depression

This study was terminated in the United States, in the United Kingdom, in Italy, .... It is testing seltorexant for depression.

In United Kingdom
DepressionDrugFrom 12 Years to 17 Years
Countries
United States, United Kingdom, Italy, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04513912

Seltorexant Compared to Quetiapine XR for depression

This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing Seltorexant Compared to Quetiapine XR for depression.

In United Kingdom
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

In United Kingdom
SchizophreniaDrugOver 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

In United Kingdom
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT05145413

KarXT for schizophrenia

This study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.